I recently placed a bulk order with a well-known genericsmanufacturer. Of the hundred odd lines I ordered, overtwenty were in short supply. Aside from the now usualvalsartan issues, almost the full range of ARBs were short.Not a single molecule of various strengths of candesartan,olmesartan or losartan was available.

摘要

The degree of dailyfrustration inpharmacy hasratcheted up anotch over the lastfew months. Drug shortagesare seriously hamperingpharmacies’ ability tofunction as normal. Theyare also having noticeableeffects on patients, whereoptimal treatments are beingdegraded by erratic supply.